Sawtooth Physical Therapy Occupational Therapist - Hand Medicare: Medicare Enrolled Practice Location: 4842 N Cortona Way Ste 100, Meridian, ID 83646 Phone: 208-888-8302 |
Adapt Therapy Llc Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3368 E Goldstone Dr, Meridian, ID 83642 Phone: 208-899-7992 Fax: 208-795-8927 |
Kameron K Barnett, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr Ste 500, Meridian, ID 83642 Phone: 208-706-7050 |
Carolyn Queck, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr, Meridian, ID 83642 Phone: 208-489-5099 |
Laura K Brunello, MOTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3080 E Gentry Way Ste 180, Meridian, ID 83642 Phone: 208-939-3334 |
Abigail Boesiger Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2463 E Gala St, Meridian, ID 83642 Phone: 208-955-7333 |
Megan Leann Wu, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1857 S Millenium Way Ste 120, Meridian, ID 83642 Phone: 208-600-0722 |
Deana M Zamzow Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2076 S Eagle Rd, Meridian, ID 83642 Phone: 208-955-7333 Fax: 208-955-7330 |
Sergey Tsema, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1259 E Pisa St, Meridian, ID 83642 Phone: 208-284-4441 |
Shawn Soren, M.S., O.T. R/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 68 S Baltic Pl, Meridian, ID 83642 Phone: 208-587-8255 |
Taylor Lynne Willis, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 509-899-1461 |
Jacqueline Christina Baxter, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1857 S Millenium Way Ste 120, Meridian, ID 83642 Phone: 208-600-0722 |
Shannon Reid, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1550 N. Crestmont Dr., Ste. E, Meridian, ID 83642 Phone: 208-898-0988 Fax: 208-898-9022 |
Joshua Baker Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr, Suite 500, Meridian, ID 83642 Phone: 208-706-7050 Fax: 208-706-7059 |
Mr. Jared Austin Purvis, OTL Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3368 E Goldstone Dr, Meridian, ID 83642 Phone: 208-899-7992 Fax: 208-795-8927 |
Sekayi Anika Malek, MOT, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2463 E Gala St, Meridian, ID 83642 Phone: 208-908-1881 |
Mary Jane Mello, MS,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 208-706-5000 |
Jennifer Bowman, LMT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2857 S Meridian Rd Ste 100, Meridian, ID 83642 Phone: 208-888-5858 Fax: 208-884-1508 |
Ashley Kophs Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1857 S Millenium Way Ste 120, Meridian, ID 83642 Phone: 208-600-0722 |
Elliot Starcevich, OTR/L Occupational Therapist - Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 68 S Baltic Pl, Meridian, ID 83642 Phone: 208-898-0988 |
News Archive
Triad Isotopes, Inc., a portfolio company of Parthenon Capital Partners, today announced that it has entered into an agreement to acquire the U.S. radiopharmacy network currently owned and operated by Covidien, a leading global healthcare products company based in Dublin, Ireland.
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts General Hospital (MGH) investigators report the first preclinical study combining antiangiogenic and anti-HER2 drugs in an animal model of brain metastatic breast cancer.
Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.
A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.
› Verified 8 days ago